RenaissanceRe (NYSE:RNR) Given Hold Rating at Wells Fargo & Co

RenaissanceRe (NYSE:RNR)‘s stock had its “hold” rating reiterated by analysts at Wells Fargo & Co in a research report issued on Thursday, December 28th.

RNR has been the topic of a number of other research reports. Zacks Investment Research raised shares of RenaissanceRe from a “sell” rating to a “hold” rating in a report on Friday, November 10th. Citigroup raised shares of RenaissanceRe from a “neutral” rating to a “buy” rating and raised their price target for the stock from $151.00 to $157.00 in a report on Thursday, November 2nd. ValuEngine cut shares of RenaissanceRe from a “buy” rating to a “hold” rating in a research report on Friday, October 6th. UBS Group raised their target price on shares of RenaissanceRe from $135.00 to $144.00 and gave the stock a “neutral” rating in a research report on Monday, November 6th. Finally, Keefe, Bruyette & Woods reaffirmed a “hold” rating and issued a $136.00 target price on shares of RenaissanceRe in a research report on Monday, October 16th. Two research analysts have rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $146.50.

Shares of RenaissanceRe (NYSE RNR) opened at $120.51 on Thursday. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.25. The stock has a market cap of $4,754.26, a P/E ratio of -26.37, a price-to-earnings-growth ratio of 1.29 and a beta of 0.67. RenaissanceRe has a 52 week low of $116.50 and a 52 week high of $152.00.

RenaissanceRe (NYSE:RNR) last posted its quarterly earnings data on Tuesday, October 31st. The insurance provider reported ($13.81) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($12.25) by ($1.56). The company had revenue of $483.22 million for the quarter, compared to analysts’ expectations of $300.46 million. RenaissanceRe had a negative net margin of 7.60% and a negative return on equity of 5.82%. The business’s quarterly revenue was up 70.0% compared to the same quarter last year. During the same quarter last year, the business posted $2.09 EPS. equities analysts anticipate that RenaissanceRe will post -8.83 earnings per share for the current fiscal year.

RenaissanceRe declared that its Board of Directors has initiated a stock repurchase program on Friday, November 10th that permits the company to repurchase $500.00 million in shares. This repurchase authorization permits the insurance provider to purchase shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company’s board believes its shares are undervalued.

In other news, CEO Kevin Odonnell sold 5,000 shares of RenaissanceRe stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $131.65, for a total value of $658,250.00. Following the completion of the sale, the chief executive officer now directly owns 190,707 shares in the company, valued at $25,106,576.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Sean G. Brosnan sold 1,391 shares of RenaissanceRe stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $135.73, for a total transaction of $188,800.43. Following the completion of the sale, the senior vice president now owns 8,405 shares of the company’s stock, valued at $1,140,810.65. The disclosure for this sale can be found here. Insiders sold 11,391 shares of company stock valued at $1,524,950 over the last ninety days. Corporate insiders own 1.80% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Janus Henderson Group PLC grew its position in RenaissanceRe by 53,631.6% during the second quarter. Janus Henderson Group PLC now owns 1,290,632 shares of the insurance provider’s stock valued at $179,463,000 after buying an additional 1,288,230 shares during the period. Dimensional Fund Advisors LP grew its position in RenaissanceRe by 1.1% during the second quarter. Dimensional Fund Advisors LP now owns 1,217,939 shares of the insurance provider’s stock valued at $169,360,000 after buying an additional 12,882 shares during the period. APG Asset Management N.V. grew its position in RenaissanceRe by 41.3% during the third quarter. APG Asset Management N.V. now owns 970,002 shares of the insurance provider’s stock valued at $131,086,000 after buying an additional 283,300 shares during the period. Northern Trust Corp grew its position in RenaissanceRe by 0.6% during the second quarter. Northern Trust Corp now owns 808,306 shares of the insurance provider’s stock valued at $112,395,000 after buying an additional 4,468 shares during the period. Finally, TimesSquare Capital Management LLC grew its position in RenaissanceRe by 6.7% during the second quarter. TimesSquare Capital Management LLC now owns 803,900 shares of the insurance provider’s stock valued at $111,782,000 after buying an additional 50,400 shares during the period. Institutional investors own 93.33% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This article was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.dispatchtribunal.com/2018/01/14/renaissancere-rnr-rating-reiterated-by-wells-fargo-co.html.

RenaissanceRe Company Profile

RenaissanceRe Holdings Ltd. provides reinsurance and insurance coverages and related services to a range of customers. The Company’s products include property, casualty and specialty reinsurance and certain insurance products principally distributed through intermediaries. Its segments include Property; Casualty and Specialty, and Other category.

Analyst Recommendations for RenaissanceRe (NYSE:RNR)

Receive News & Ratings for RenaissanceRe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenaissanceRe and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply